208 related articles for article (PubMed ID: 34390418)
1. Cardiac risk stratification of breast cancer patients in a cardio-oncology clinic.
Doukas PG; Patel RN; Venkatesh V; Khan SS; Baldridge A; Akhter N
Breast Cancer Res Treat; 2021 Nov; 190(1):133-142. PubMed ID: 34390418
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights.
Shibata T; Nohara S; Morikawa N; Shibao K; Ito S; Shibata R; Toh U; Nagafuji K; Fukami K; Fukumoto Y
Eur J Prev Cardiol; 2023 Dec; 30(18):1941-1949. PubMed ID: 37352112
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience of patients referred to a multidisciplinary cardio-oncology clinic: an observational cohort study.
Kappel C; Rushton M; Johnson C; Aseyev O; Small G; Law A; Ivars J; Dent S
Curr Oncol; 2019 Jun; 26(3):e322-e327. PubMed ID: 31285675
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience of a cardio-oncology consultation at a tertiary university hospital in Portugal: An observational study.
Fiuza M; Magalhães A; Nobre Menezes M; Costa P; Abreu Ribeiro L; Abreu C; Brás R; Vieira J; Duarte AI; Morais P; Silva B; Costa L; Pinto FJ
Rev Port Cardiol; 2022 Dec; 41(12):979-984. PubMed ID: 36153294
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics of patients referred to cardio-oncology clinic].
Liang L; An T; Zhao XM; Huang LY; Tian PC; Guan JY; Zou CH; Zhang J; Zhang YH
Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(28):2183-2186. PubMed ID: 37482731
[TBL] [Abstract][Full Text] [Related]
6. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.
Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D
Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Patients' Phenotypes, Guideline-Directed Recommendations Compliance and Rates of Cardiotoxicity between Caribbean and United States Cardio-oncology Programs.
Piña P; Taveras A; Khan A; Coyle J; Bueno V; Shah N; Cuello L; Collado S; Mauer A; Danciu S; Herrera CJ
Glob Heart; 2022; 17(1):67. PubMed ID: 36199568
[TBL] [Abstract][Full Text] [Related]
8. Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer.
Kosalka P; Johnson C; Turek M; Sulpher J; Law A; Botros J; Dent S; Aseyev O
Curr Oncol; 2019 Jun; 26(3):e314-e321. PubMed ID: 31285674
[TBL] [Abstract][Full Text] [Related]
9. Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice.
Tini G; Cuomo A; Battistoni A; Sarocchi M; Mercurio V; Ameri P; Volpe M; Porto I; Tocchetti CG; Spallarossa P
Int J Cardiol; 2022 Feb; 349():134-137. PubMed ID: 34848212
[TBL] [Abstract][Full Text] [Related]
10. Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast Cancer.
Curigliano G; de Azambuja E; Lenihan D; Calabrò MG; Cardinale D; Cipolla CM
Oncologist; 2019 Nov; 24(11):e1034-e1043. PubMed ID: 31064888
[TBL] [Abstract][Full Text] [Related]
11. Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction.
Hussain Y; Drill E; Dang CT; Liu JE; Steingart RM; Yu AF
Breast Cancer Res Treat; 2019 May; 175(1):239-246. PubMed ID: 30721443
[TBL] [Abstract][Full Text] [Related]
12. Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.
Yu AF; Mukku RB; Verma S; Liu JE; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
Breast Cancer Res Treat; 2017 Nov; 166(1):241-247. PubMed ID: 28710537
[TBL] [Abstract][Full Text] [Related]
13. Activity and outcomes of a cardio-oncology service in the United Kingdom-a five-year experience.
Pareek N; Cevallos J; Moliner P; Shah M; Tan LL; Chambers V; Baksi AJ; Khattar RS; Sharma R; Rosen SD; Lyon AR
Eur J Heart Fail; 2018 Dec; 20(12):1721-1731. PubMed ID: 30191649
[TBL] [Abstract][Full Text] [Related]
14. Lessons learnt in the first year of an Australian pediatric cardio oncology clinic.
Toro C; Felmingham B; Jhadav M; Celermajer DS; La Gerche A; O'Sullivan J; Kumar S; Mateos MK; Fulbright J; Govender D; Collier L; Cheung M; Eisenstat DD; Lange PW; Ayer J; Elliott DA; Conyers R
Cardiooncology; 2023 Dec; 9(1):45. PubMed ID: 38062530
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial.
Banke A; Fosbøl EL; Møller JE; Gislason GH; Andersen M; Bernsdorf M; Jensen MB; Schou M; Ejlertsen B
Eur J Heart Fail; 2018 Oct; 20(10):1447-1453. PubMed ID: 29493047
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the safety of continuing trastuzumab despite overt left ventricular dysfunction.
Barron CC; Alhussein MM; Kaur U; Cosman TL; Tyagi NK; Brown M; Mukherjee SD; Ellis PM; Dhesy-Thind S; Leong DP
Curr Oncol; 2019 Aug; 26(4):240-246. PubMed ID: 31548803
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Risk and Level of Statin Use Among Women With Breast Cancer in a Cardio-Oncology Clinic.
Shum K; Solivan A; Parto P; Polin N; Jahangir E
Ochsner J; 2016; 16(3):217-24. PubMed ID: 27660568
[TBL] [Abstract][Full Text] [Related]
18. Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients With Cancer.
Hussain M; Hou Y; Watson C; Moudgil R; Shah C; Abraham J; Budd GT; Tang WHW; Finet JE; James K; Estep JD; Xu B; Hu B; Cremer P; Jellis C; Grimm RA; Greenberg N; Popovic ZB; Cho L; Desai MY; Nissen SE; Kapadia SR; Svensson LG; Griffin BP; Cheng F; Collier P
Am J Cardiol; 2020 Dec; 137():118-124. PubMed ID: 32991858
[TBL] [Abstract][Full Text] [Related]
19. Cardio-oncology: where do we stand for in Belgium?
Lancellotti P; De Pauw M; Claeys M
Acta Cardiol; 2021 Apr; 76(2):204-208. PubMed ID: 31967938
[TBL] [Abstract][Full Text] [Related]
20. Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic.
Barros-Gomes S; Herrmann J; Mulvagh SL; Lerman A; Lin G; Villarraga HR
Cardiooncology; 2016 Apr; 2(1):5. PubMed ID: 33530144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]